Eur Rev Med Pharmacol Sci 2026; 30 (1): 46-50
DOI: 10.26355/eurrev_202601_37648

Fulminant Fournier gangrene in bladder cancer: case report and review of the literature

M. De Felice, M. Tammaro, M. Caterino, V. Nacca, R. Cangiano

Department of Clinical Oncology, ASL Caserta, P.O. Piedimonte Matese, Caserta, Italy. marco.defelice1993@gmail.com


BACKGROUND: The introduction of new target therapies and immunotherapy combinations has dramatically improved the prognosis of cancer patients. Surgery and radiotherapy currently represent the cornerstones of loco-regional management, both for palliative and curative purposes. It is no coincidence, therefore, that in recent years the frequency of complications once considered rare has increased.

CASE REPORT: Here we present the case of a patient affected by metastatic bladder cancer whose treatments (surgery, radiotherapy, and targeted therapy) favored a rapid and acute onset of Fournier syndrome. The fulminant course prevented the establishment of a potentially effective treatment.

CONCLUSIONS: Fournier gangrene is an acute perineal necrosis caused by anaerobic bacteria. Management is complex and requires a quick multidisciplinary approach, even though, among cancer patients, mortality is very high.

Graphical Abstract

Free PDF Download

To cite this article

M. De Felice, M. Tammaro, M. Caterino, V. Nacca, R. Cangiano
Fulminant Fournier gangrene in bladder cancer: case report and review of the literature

Eur Rev Med Pharmacol Sci
Year: 2026
Vol. 30 - N. 1
Pages: 46-50
DOI: 10.26355/eurrev_202601_37648

Publication History

Submission date: 31 Oct 2025

Revised on: 20 Nov 2025

Accepted on: 02 Dec 2025

Published online: 30 Jan 2026